Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Chenbin Zhang
Integration of network pharmacology, transcriptomics, and metabolomics
Back to Journals » Drug Design, Development and Therapy » Volume 19 Authors Zhang C , Chen F, Jiang Y, Deng J , Yan X, Yin X, Su B, Liu W Received 10 March 2025 Accepted for publication 15 May 2025 Published 2 June 2025 Volume 2025:19 Pages 4665—4688 DOI https://doi.org/10.2147/DDDT.S521626 Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 3 Editor who approved publication: Professor Yan Zhu Chenbin Zhang,1 Fang Chen,2 Yu Jiang,2 Jun Deng,1 Xiao Yan,1...
High-extinction-ratio low-voltage dual-racetrack modulator for low-power DAC-less PAM-4 modulation
Author Affiliations Zhaobang Zeng,1,2,3,4 Lemeng Leng,1,2,3,4 Peiyan Zhao,1,2,3,4 Chenbin Zhang,1,2,3,4 Ding Ding,1,2,3,4 Dun Mao,5 Tingyi Gu,5 and Wei Jiang1,2,3,4,* 1National Laboratory of Solid State Microstructures, Nanjing 210093, China 2College of Engineering and Applied Sciences, Nanjing University, Nanjing 210093, China 3Key Laboratory of Intelligent Optical Sensing and Manipulation (Nanjing University), Ministry of Education, Nanjing 210093, China 4Collaborative Innovation Center of...
New Catalogue on Medical Devices Classification
To view this article you need a PDF viewer such as Adobe Reader. If you can't read this PDF, you can view its text here. Go back to the PDF . New Catalogue on Medical Devices Classification On 31 August 2017, the China Food and Drug Administration (“CFDA”) promulgated the Catalogue on Medical Device Classification (2017 Edition) (“Catalogue 2017”). The Catalogue 2017 will be implemented on 1 August 2018.
PRC Supreme People's Court clarifies certain aspects of Shareholders' Rights
On 25 August 2017 the Supreme People’s Court (“SPC”) of the People’s Republic of China (“PRC”) promulgated the Provisions of the Supreme People's Court on Several Issues Relating to Application of the PRC Company Law (IV) (“Interpretation IV”). Interpretation IV has come into force on 1 September 2017.
Supplementary Rules Promulgated regarding Application Documents and Onsite Inspection for Registration of Infant Milk Powder Formula
Following the promulgation of the Administrative Measures for the Registration of Infant Milk Powder Formula (“Measures”) on 6 June 2016 and effective as of 1 October 2016, the China Food and Drug Administration ("CFDA") further promulgated two detailed rules on 16 November 2016, i.e. Application Documents and their Request for Registration of Infant Milk Power Formula (“Application Documents Request”) and Onsite Inspection Key Point and Judgment Principle for Registration of Infant Milk...
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Chenbin
Contact Chenbin, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack